Bullseye Asset Management LLC Novo Cure LTD Transaction History

Bullseye Asset Management LLC

  • $204 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$124.11 - $190.17 $6.67 Million - $10.2 Million
-53,745 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$112.16 - $174.14 $842,770 - $1.31 Million
7,514 Added 16.25%
53,745 $9.3 Million
Q3 2020

Nov 12, 2020
BUY
$58.05 - $111.31 $62,113 - $119,101
1,070 Added 2.37%
46,231 $5.15 Million
Q2 2020

Aug 11, 2020
BUY
$57.2 - $74.41 $2.58 Million - $3.36 Million
45,161 New
45,161 $2.68 Million

Others Institutions Holding NVCR

# of Institutions
265
Shares Held
77.1M
Call Options Held
751K
Put Options Held
293K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.59B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email